MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS).

IF 2 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Jiali Lu, Feilan Xuan, Aixue Chen, Ruiying Jin, Weimei Zhou, Yongju Ye, Yuefang Ren
{"title":"MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS).","authors":"Jiali Lu,&nbsp;Feilan Xuan,&nbsp;Aixue Chen,&nbsp;Ruiying Jin,&nbsp;Weimei Zhou,&nbsp;Yongju Ye,&nbsp;Yuefang Ren","doi":"10.5603/EP.a2023.0020","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Polycystic ovarian syndrome (PCOS) is a common endocrinopathy in women. MicroRNAs (miRNAs) have been proven to play a crucial role in balancing the proliferation and apoptosis of granulosa cells (GCs) in PCOS.</p><p><strong>Material and methods: </strong>The miRNA of PCOS was screened by bioinformatics analysis, and microRNA 646 (miR-646) was found to be involved in insulin-related pathways by enrichment analysis. The cell counting kit-8 (CCK-8), cell colony formation, and the 5-ethynyl-2'-deoxyuridine (EdU) assays were used to explore the effect of miR-646 on proliferation of GCs, flow cytometry was used to measure the cell cycle and apoptosis, and Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) were used to explore the biological mechanism of miR-646. The human ovarian granulosa cells KGN were selected by measuring the miR-646 and via insulin-like growth factor 1 (IGF-1) levels and used for cell transfection.</p><p><strong>Results: </strong>Overexpressed miR-646 inhibited KGN cell proliferation, and silenced miR-646 advanced it. Most cells were arrested in the S phase of cell cycle with overexpressed-miR-646, while after silencing miR-646, cells were arrested in the G2/M phase. And the miR-646 mimic raised apoptosis in KGN cells. Also, a dual-luciferase reporter proved the regulation effect of miR-646 on IGF-1, miR-646 mimic inhibited IGF-1, and miR-646 inhibitor advanced IGF-1. The cyclin D1, cyclin-dependent kinase 2 (CDK2), and B-cell CLL/lymphoma 2 (Bcl-2) levels were inhibited with overexpressed-miR-646, while silenced-miR-646 promoted their expression, and the bcl-2-like protein 4 (Bax) level was the opposite. This study found that silenced-IGF1 antagonized the promotive effect of the miR-646 inhibitor on cell proliferation.</p><p><strong>Conclusions: </strong>MiR-646 inhibitor treatment can promote the proliferation of GCs by regulating the cell cycle and inhibiting apoptosis, while silenced-IGF-1 antagonizes it.</p>","PeriodicalId":11551,"journal":{"name":"Endokrynologia Polska","volume":"74 3","pages":"305-314"},"PeriodicalIF":2.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endokrynologia Polska","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5603/EP.a2023.0020","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Polycystic ovarian syndrome (PCOS) is a common endocrinopathy in women. MicroRNAs (miRNAs) have been proven to play a crucial role in balancing the proliferation and apoptosis of granulosa cells (GCs) in PCOS.

Material and methods: The miRNA of PCOS was screened by bioinformatics analysis, and microRNA 646 (miR-646) was found to be involved in insulin-related pathways by enrichment analysis. The cell counting kit-8 (CCK-8), cell colony formation, and the 5-ethynyl-2'-deoxyuridine (EdU) assays were used to explore the effect of miR-646 on proliferation of GCs, flow cytometry was used to measure the cell cycle and apoptosis, and Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) were used to explore the biological mechanism of miR-646. The human ovarian granulosa cells KGN were selected by measuring the miR-646 and via insulin-like growth factor 1 (IGF-1) levels and used for cell transfection.

Results: Overexpressed miR-646 inhibited KGN cell proliferation, and silenced miR-646 advanced it. Most cells were arrested in the S phase of cell cycle with overexpressed-miR-646, while after silencing miR-646, cells were arrested in the G2/M phase. And the miR-646 mimic raised apoptosis in KGN cells. Also, a dual-luciferase reporter proved the regulation effect of miR-646 on IGF-1, miR-646 mimic inhibited IGF-1, and miR-646 inhibitor advanced IGF-1. The cyclin D1, cyclin-dependent kinase 2 (CDK2), and B-cell CLL/lymphoma 2 (Bcl-2) levels were inhibited with overexpressed-miR-646, while silenced-miR-646 promoted their expression, and the bcl-2-like protein 4 (Bax) level was the opposite. This study found that silenced-IGF1 antagonized the promotive effect of the miR-646 inhibitor on cell proliferation.

Conclusions: MiR-646 inhibitor treatment can promote the proliferation of GCs by regulating the cell cycle and inhibiting apoptosis, while silenced-IGF-1 antagonizes it.

MicroRNA-646在多囊卵巢综合征(PCOS)中通过胰岛素样生长因子1 (IGF-1)抑制卵巢颗粒细胞的增殖。
简介:多囊卵巢综合征(PCOS)是一种常见的女性内分泌疾病。MicroRNAs (miRNAs)已被证明在PCOS颗粒细胞(GCs)的增殖和凋亡平衡中起着至关重要的作用。材料与方法:通过生物信息学分析筛选PCOS的miRNA,富集分析发现microRNA 646 (miR-646)参与胰岛素相关通路。采用细胞计数试剂盒-8 (CCK-8)、细胞集落形成、5-乙基-2′-脱氧尿苷(EdU)检测探讨miR-646对胃癌细胞增殖的影响,采用流式细胞术检测细胞周期和凋亡情况,采用Western blot和定量实时聚合酶链反应(qRT-PCR)技术探讨miR-646的生物学机制。通过测量miR-646和胰岛素样生长因子1 (IGF-1)水平选择人卵巢颗粒细胞KGN,并用于细胞转染。结果:过表达的miR-646抑制KGN细胞增殖,而沉默的miR-646则促进KGN细胞增殖。过表达miR-646后,大多数细胞被阻滞在细胞周期的S期,而沉默miR-646后,细胞被阻滞在G2/M期。miR-646模拟物增加了KGN细胞的凋亡。此外,双荧光素酶报告基因证实了miR-646对IGF-1的调节作用,miR-646模拟物抑制IGF-1, miR-646抑制剂促进IGF-1。过表达mir -646可抑制细胞周期蛋白D1、细胞周期蛋白依赖性激酶2 (CDK2)和b细胞CLL/淋巴瘤2 (Bcl-2)水平,而沉默mir -646可促进其表达,Bcl-2样蛋白4 (Bax)水平相反。本研究发现,沉默的igf1可以拮抗miR-646抑制剂对细胞增殖的促进作用。结论:MiR-646抑制剂处理可通过调节细胞周期和抑制细胞凋亡促进GCs的增殖,而沉默的igf -1可拮抗GCs。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endokrynologia Polska
Endokrynologia Polska ENDOCRINOLOGY & METABOLISM-
CiteScore
2.60
自引率
9.50%
发文量
129
审稿时长
6-12 weeks
期刊介绍: "Endokrynologia Polska" publishes papers in English on all aspects of clinical and experimental endocrinology. The following types of papers may be submitted for publication: original articles, reviews, case reports, postgraduate education, letters to the Editor (Readers’ Forum) and announcements of scientific meetings, conferences and congresses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信